Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HIV Pre-exposure Prophylaxis Prescribing Through Telehealth.
Stekler JD, McMahan V, Ballinger L, Viquez L, Swanson F, Stockton J, Crutsinger-Perry B, Kern D, Scott JD. Stekler JD, et al. Among authors: mcmahan v. J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):e40-e42. doi: 10.1097/QAI.0000000000001621. J Acquir Immune Defic Syndr. 2018. PMID: 29280768 No abstract available.
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.
Liu A, Glidden DV, Anderson PL, Amico KR, McMahan V, Mehrotra M, Lama JR, MacRae J, Hinojosa JC, Montoya O, Veloso VG, Schechter M, Kallas EG, Chariyalerstak S, Bekker LG, Mayer K, Buchbinder S, Grant R; iPrEx Study team. Liu A, et al. Among authors: mcmahan v. J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):528-37. doi: 10.1097/QAI.0000000000000351. J Acquir Immune Defic Syndr. 2014. PMID: 25230290 Free PMC article. Clinical Trial.
The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
Solomon MM, Schechter M, Liu AY, McMahan VM, Guanira JV, Hance RJ, Chariyalertsak S, Mayer KH, Grant RM; iPrEx Study Team. Solomon MM, et al. Among authors: mcmahan vm. J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):281-6. doi: 10.1097/QAI.0000000000000857. J Acquir Immune Defic Syndr. 2016. PMID: 26413853 Free PMC article. Clinical Trial.
Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis.
Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM. Glidden DV, et al. Among authors: mcmahan v. J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):177-182. doi: 10.1097/QAI.0000000000001475. J Acquir Immune Defic Syndr. 2017. PMID: 28639995 Free PMC article. Clinical Trial.
Baseline Characteristics Explain Differences in Effectiveness of Randomization to Daily Oral TDF/FTC PrEP Between Transgender Women and Cisgender Men Who Have Sex With Men in the iPrEx Trial.
Mehrotra ML, Westreich D, McMahan VM, Glymour MM, Geng E, Grant RM, Glidden DV. Mehrotra ML, et al. Among authors: mcmahan vm. J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):e94-e98. doi: 10.1097/QAI.0000000000002037. J Acquir Immune Defic Syndr. 2019. PMID: 31192894 Free PMC article. Clinical Trial. No abstract available.
61 results